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52 Oxford Street, Cambridge MA 02138
Abstract
In a recently introduced transgenic multicolor labeling strategy called “Brainbow,” Cre-lox
recombination is used to create a stochastic choice of expression among fluorescent proteins
(XFPs), resulting in the indelible marking of mouse neurons with multiple, distinct colors. This
method has been adapted to non-neuronal cells in mice and to neurons in fish and flies, but has yet
to realize its full potential in the mouse brain. Here, we present several new lines of mice that
overcome limitations of the initial lines and an adaptation of the method for use in adeno-
associated viral (AAV) vectors. We also provide technical advice about how best to image
Brainbow transgenes.
INTRODUCTION
The discovery that recombinant jellyfish green fluorescent protein (GFP) fluoresces when
expressed in heterologous cells1 has led to a vast array of powerful methods for marking and
manipulating cells, subcellular compartments and molecules. The discovery or design of
numerous spectral variants2–13 (together called XFPs; ref. 14), expanded the scope of the
“GFP revolution” by enabling discrimination of nearby cells or processes labeled with
contrasting colors. At least in the nervous system, however, two or three colors are far too
few, because each axon or dendrite approaches hundreds or thousands of other processes in
the crowded neuropil of the brain.
Several years ago, we developed a transgenic strategy called Brainbow15 that addresses this
problem by marking each neuron with a different color. In this method, three or four XFPs
are incorporated into a transgene, and the Cre-loxP recombination system16 is used to make
a stochastic “choice” of a single XFP to be expressed from the cassette. Because multiple
cassettes are integrated at a single genomic site, and choice within each cassette is made
independently, combinatorial expression can endow individual neurons with one of ~100
colors, endowing nearby neurons with distinct spectral identities.
If Cre recombinase is expressed transiently, descendants of the initially marked cell inherit
the color of their progenitor. Accordingly, the Brainbow method has been adapted for use in
lineage analysis in non-neural tissues of mice17–21. In addition, it has been adapted for
analyzing neuronal connectivity, cell migration and lineage in fish22, 23 and flies24, 25. In
disappointing contrast, the method has been little used in the mouse nervous system26. We
believe that the main reasons are limitations of the initial set of Brainbow transgenic mice.
These include suboptimal fluorescence intensity, failure to fill all axonal and dendritic
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processes, and disproportionate expression of the “default” (i.e., non-recombined) XFP in
the transgene. We have now addressed several of these limitations, and present a new set of
Brainbow reagents here. In addition, we provide guidelines for imaging Brainbow tissue.
RESULTS
Design of Brainbow 3.0 transgenes
As a first step in improving Brainbow methods, we sought XFPs with minimal tendency to
aggregate in vivo, high photostability, and maximal stability to fixation with
paraformaldehyde. Because some XFPs that ranked highly in cultured cells performed
poorly in vivo, we therefore generated transgenic lines from 15 XFPs (Supplementary Table
1 and refs. 2–13). Of the XFPs tested in this way, 7 were judged suitable: mTFP1, EGFP,
EYFP, mOrange2, TagRFPt, tdTomato, and mKate2.
From these XFPs, we chose three, based on the criteria of minimal spectral overlap and
minimal sequence homology. These were mOrange2 from a coral (Excitation peak
[Ex]549nm, Emission peak [Em]565nm), EGFP from a jelly fish (Ex488nm, Em507nm),
and mKate2, from a sea anemone (Ex588nm, Em635nm)2, 9, 11. Our reason for minimizing
sequence homology was to ensure that the XFPs would be antigenically distinct, in contrast
to spectrally distinct but antigenically indistinguishable jellyfish variants (EBFP, ECFP,
EGFP, and EYFP). Exploiting this property, we generated antibodies to them in different
host species (rabbit anti-mCherry/mOrange2/tdTomato, chicken anti-EGFP/EYFP/ECFP
and guinea pig anti-mKate2/TagBFP/TagRFP; Supplementary Table 1). Tests in transfected
cultured cells confirmed lack of cross-reactivity (data not shown).
Next, we addressed the need to fill all parts of the cell evenly. Unmodified XFPs labeled
somata so strongly that nearby processes were difficult to resolve, whereas palmitoylated
derivatives, which targeted the XFPs to the plasma membrane, were selectively transported
to axons and labeled dendrites poorly15. We therefore generated farnesylated derivatives27,
which were trafficked to membranes of all neurites (see below).
Based on these results, we generated “Brainbow 3.0” transgenic lines incorporating
farnesylated derivatives of mOrange2, EGFP, and mKate2. We retained the “Brainbow 1”
format15 in which incompatible wild-type and mutant lox sites are concatenated, so that Cre
recombinase yields a stochastic choice among XFPs (Fig. 1a,b). We also retained two other
features of the Brainbow 1 strategy. First, we used neuron-specific regulatory elements from
the thy1 gene14 because it promotes high levels of transgene expression in many, although
not all, neuronal types; other promoter-enhancer sequences that we tested support
considerably lower levels of expression21. Second, we generated transgenic lines by
injection into oocytes because this method leads to integration of multiple copies of the
cassette and thus a broad spectrum of outcomes15, 28; by contrast, “knock-in” lines generated
by homologous recombination contain one or two copies of the cassette (as heterozygotes or
homozygotes, respectively), and thus a smaller number of possible color combinations17–20.
Design of Brainbow 3.1 and 3.2 transgenes
In Brainbow 1, 2 and 3.0 (Fig. 1a,b), one XFP is expressed “by default” in Cre-negative
cells. The presence of a “default” XFP has both drawbacks and advantages. In cases of
limited Cre expression this XFP is expressed in a majority of cells, reducing spectral
diversity among recombined neurons. On the other hand, incorporation of a “default” XFP
allows one to screen numerous lines in the absence of a Cre reporter to assess the the
number and types of cells within which XFPs could be expressed following recombination.
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To eliminate the default XFP while retaining the ability to assess expression in the absence
of Cre we adopted the following strategy. First, we incorporated three rather than two pairs
of incompatible lox sites, which allowed insertion of a “stop cassette”29 into a first position.
With this modification, the three XFPs were expressed only in Cre-positive neurons giving
more spectral diversity. Second, we inserted a fourth XFP, Phi-YFP (from the hydrozoa,
Phialidium)4, which is antigenically distinct from the other three, into the stop cassette. We
mutated Phi-YFP to eliminate its endogenous fluorescence (PhiYFP Y65A), fused it to a
nuclear localization sequence and generated antibodies to it in rat. In “Brainbow 3.1” mice
generated from this cassette (Fig. 1c), one can screen sections with rat-anti-Phi-YFP prior to
Cre recombination (Supplementary Fig. 1).
Finally, we inserted a sequence that stabilizes mRNAs, called a woodchuck hepatitis virus
posttranscriptional regulatory element (WPRE) to the 3’ untranslated sequences following
each XFP. The WPRE has been used in many cases to increase protein levels produced by
viral vectors and transgenes30, 31. We call lines incorporating the WPRE “Brainbow 3.2”
(Fig. 1d).
Characterization of Brainbow 3 mice
We generated 31 lines of transgenic mice from the Brainbow 3.0, 3.1 and 3.2 cassettes.
Offspring were crossed to several Cre transgenic lines32–37, leading to multicolor spectral
labeling of neuronal populations in numerous regions including cerebral cortex, brainstem,
cerebellum, spinal cord and retina (Fig. 1e–i, Supplementary Table 2, Supplementary Fig. 2
and Supplementary Movies 1 and 2). Intensity of expression varied markedly among lines,
making quantitative comparison of dubious value but the strongest expressing lines were
those that incorporated the WPRE (Brainbow 3.2).
Analysis of these lines confirmed their advantages over Brainbow 1 and 2 lines15. First, the
use of farnesylated XFPs led to concentration of the XFPs at the plasma membrane (Fig.
1g). As a consequence, somata were less intensely labeled in Brainbow 3 than in Brainbow 1
mice, so processes could be visualized without saturating somata (Fig. 2a,b and
Supplementary Fig. 3). Use of farnesylated XFPs also improved labeling of fine processes
and dendritic spines (Fig. 2a,b insets). Second, the ability to immunostain all three XFPs
enabled enhancement of the intrinsic fluorescence without losing color diversity (Fig. 2c,d
and Supplementary Fig. 4). Third, XFP fluorescence is only visible in Cre-positive cells,
correcting the color imbalance caused by “default” XFP expression in cells that were Cre-
negative or expressed Cre at low levels in Brainbow 1 and 2 lines (Fig. 2e–i and
Supplementary Fig. 5). Thus, Brainbow 3 lines are likely to be more useful than Brainbow 1
and 2 lines for multicolor labeling.
Brainbow with self-excising cre recombinase
In Brainbow 1–3 lines, the cassette encodes XFPs separated by lox sites; Cre recombinase is
supplied from a separate transgene. For analysis of connectivity in mouse mutants, breeding
two transgenes (Brainbow and Cre) into an already complex background is cumbersome.
We therefore attempted to combine XFPs and Cre in a single cassette. In this transgene,
called Autobow, we substituted a self-excising Cre recombinase38 for the “STOP”
sequences in Brainbow 3.1 (Fig. 3a). The Thy1 regulatory elements lead to expression of
Cre in differentiated neurons; Cre then simultaneously activates an XFP and excises itself.
We generated three founders using this construct. Two were sacrificed as adults, and both
expressed combinatorial expression of XFPs in multiple neurons (Fig. 3b and
Supplementary Fig. 3e). We were concerned that precocious Cre activation in the germ line
might lead to loss of the cassette. We therefore established a line from the third founder, and
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examined mice in the second and sixth generations. Color range was limited in this line,
perhaps because only a few copies had been integrated into the genome, but the variety of
colors and level of expression were similar in both generations (Fig. 3c,d). Thus, Autobow
transgenes can be stably maintained.
Brainbow using Flp recombinase and Frt sites
A second recombination system, orthogonal to Cre-Lox, could be used to independently
control expression of distinct XFPs in, for example, excitatory and inhibitory neurons. In
this way, the color of a neuron could denote cell identity, a feature lacking in currently
available Brainbow lines15, 17–20. We therefore tested a second recombination system, in
which Flp recombinase acts on Frt sites. The Flp-Frt system has been used in conjunction
with Cre-Lox in mice16, and in Brainbow-like transgenes in Drosophila24, 25.
We tested previously described mutant Frt sites39, 40 to find incompatible sets
(Supplementary Fig. 6) and used these sets to construct “Flpbow” lines (Fig. 4a,b). In one of
the cassettes, we fused the XFPs to an epitope tag41, allowing discrimination of cells labeled
by Cre- and Flp-driven cassettes (Supplementary Fig. 7). When mated to Flp-expressing
mice42,43, multicolor labeling was observed (Fig. 4c,d). Although the few lines tested to date
exhibit narrow expression patterns, these results demonstrate that Flp- and Cre-based
Brainbow systems can be used in combination.
Brainbow adeno-associated viral vectors
In parallel to generation of Brainbow transgenic lines, we generated adeno-associated viral
(AAV) vectors to provide spatial and temporal control over expression and to make the
method applicable to other species. Because the Brainbow 3.1 cassette described above is
>6kB but the capacity of AAV vectors is <5kB, we reengineered the cassette. Based on
results from initial tests illustrated in Supplementary Fig. 8, we devised a scheme in which
lox sites with left or right element mutations44 were used for unidirectional Cre-dependent
inversion (Fig. 5a,b). Farnesylated XFPs were positioned in reverse orientation to prevent
Cre-independent expression, and WPRE elements were added to increase expression. In this
design, recombination can lead to three outcomes from two XFPs: XFP1, XFP2 or neither.
We generated two AAVs with 2 XFPs each, such that co-infection would lead to a minimum
of 8 hues (3 × 3 −1; Fig. 5c). Because AAV can infect cells at high multiplicity, the number
of possible colors is >>8. An additional feature is that excision of the non-expressed XFP in
a second step (#3 and #4 in Fig. 5a) enhances and equalizes expression of the remaining
XFP (Fig. 5d,e).
We infected cortex, cerebellum and retina of Cre transgenic mice with these vectors. When
examined 3–5 weeks later, neurons were labeled in multiple colors (Fig. 2f–j and
Supplementary Movie 3). Near injection sites, high levels of infectivity led to coexpression
of all XFPs in single cells and “gray-white” labeling. The variety of colors increased with
distance from these sites, then decreased again in sparsely injected regions, presumably
because each labeled neuron received only one virion (Supplementary Fig. 9).
Methods to optimize Brainbow imaging
Obtaining high quality images from of tissues expressing Brainbow transgenes is
challenging. Because colors are derived by mixing images of multiple fluorophores over a
wide range of concentrations, factors that differentially affect the labels degrade the final
image. In addition, it is usually necessary to image a tissue volume rather than a single
section, so methods for taking image stacks must be optimized. Here, we summarize
guidelines for imaging Brainbow tissue:
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Sample preparation—To minimize background, section thickness should be less than the
working distance of the objective, generally <100µm for high numerical aperture [NA]
lenses. It is also important to match the refractive indices of the immersion medium and the
sample, because chromatic aberrations caused by mismatches between these values lead to
spatial offsets between color channels (Supplementary Fig. 10).Commercial antifade
mountants such as VECTASHIELD®, or ProLong® Gold that have refractive indices of
~1.47 are optimal for objectives that use glycerin as the immersion medium. Polyvinyl
alchohol mountants (such as Mowiol® 4–88) provide a better match for oil immersion
(~1.52) objectives.
Confocal laser scanning microscopy—Epifluoresence microscopy can be used for
imaging thin sections (<10µm) or monolayer cultures but confocal microscopes are
preferable for thick specimens because they avoid contamination by light from outside the
plane of focus. Newly developed 2 photon multi-XFP imaging techniques are also
useful45–47. Apochromatic or fluorite microscope objectives that are corrected for three or
more colors are strongly recommended.Most lens manufacturers specify preferred oils and
coverslips. Using the wrong oil or coverslip degrades sharpness of focus and increases
chromatic aberration.
Fluorophores with overlap in the excitation or emission spectra should be imaged
sequentially rather than simultaneously to minimize fluorescence crosstalk and thereby
optimize color separation. Laser power should be set as low as possible for several reasons.
First, all planes are bleached as each image plane is scanned so generation of stacks leads to
gradual bleaching and decreased signal through the stack. Second, because each fluorophore
bleaches at a different rate, colors may shift during imaging. Third, linear signaling requires
that fluorophores emit photons at submaximal rates; at higher excitation intensities only the
out of focus signal is increased48. Fourth, if one fluorophore species is saturated but another
is not, small changes in laser power will affect their intensity differently, leading to color
change. With high NA objectives, laser power of just a few milliwatts is saturating; this is
generally a small percentage of the total power the laser can provide.
Having adjusted the laser power to a low level, the photmuliplier tubes (PMT) voltages and
digital gains must be set to relatively high values. In some confocal microscopes it is
possible to compensate for signal loss from deep layers by automatic adjustment of laser
power, PMT voltage or digital gain as a function of depth. Imaging parameters can be
adjusted to obtain images with similar signal ranges throughout the stack.
Image processing—Brainbow images must be post-processed to maximize color
information, but care is needed to avoid introducing artifacts. Often, one begins by reducing
noise. Because confocal laser scanning of multicolor stacks is generally done at speeds of ~1
µs per pixel or less to save time, the small number of photons collected for each pixel gives
rise to sufficient shot noise to cause perceptible local color differences. This problem can be
minimized by slower scanning or averaging of multiple scans, but when this is infeasible,
simple filtering and deconvolution methods are helpful (Fig. 6a–c). For example, median or
Gaussian filters with 0.5–2 pixel radius reduces color noise, but at the expense of resolution.
Deconvolution algorithms (see Online Methods) are more challenging to use than simple
filters but can remove color noise without compromising spatial resolution (Supplementary
Fig. 11).
Subsequent processing steps can expand the detectable color range and correct for color
shifts (Fig. 6 d,e). To obtain easily perceived color differences, pixel intensity values for
each channel in each image are normalized to the same minimum and maximum intensity
values for that color in the whole image stack. This linearly stretches all channels and
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images to the full dynamic range. Color shifts also arise because illumination strength is
generally uneven across the imaging field and differs among lasers. This effect can be
attenuated by intensity or shading correction for each channel46, 49. The resulting composite
RGB images provide maximum color separation for viewing by eye (Fig. 6f).
DISCUSSION
The goal of the work reported here was to design, generate and characterize improved
reagents for multicolor “Brainbow” imaging of neurons in mice. First, we generated new
transgenic lines that overcome some limitations of the Brainbow 1 and 2 lines that are
currently available15. Improvements were substitution of XFPs (especially red and orange
fluorescent proteins) that are more photostable and less prone to aggregation than those used
initially; use of XFPs with minimal sequence homology so they could be immunostained
separately; farnesylation of the XFPs for even staining of somata and the finest processes;
insertion of a “stop” cassette to increase color variety by eliminating broad expression of a
“default” XFP; inclusion of a non-fluorescent marker in the default position to facilitate
screening of multiple lines; and insertion of a WPRE to boost expression (Figs. 1 and 2).
These lines under control of regulatory elements from the Thy-1 gene enables marking of
many but not all neuronal types. To date, elements tested other than those from the Thy1
gene do not support the high expression levels needed to image Brainbow 1 and 2 material.
The ability to immunostain provided by Brainbow 3 cassettes may allow weaker promoters
to be used.
Second, we designed two additional transgenes and performed initial tests to demonstrate
that they can be used effectively in vivo. One, called Autobow, incorporates a self-excising
Cre recombinase. Autobow lacks the temporal and spatial control afforded by use of specific
Cre lines or ligand-activated Cre (CreER). However, because it does not require generation
of double transgenics, it may be useful for rapid screening of neuronal morphology in
mutant mice or mice submitted to various experimental interventions (e.g., drug treatments).
The other novel transgene, Flpbow, replaces Lox sites by Frt sites, so that recombination can
be controlled by Flp recombinase rather than Cre recombinase. Flpbow 3 also incorporates
an epitope tag so that XFPs in Flpbow can be distinguished immunohistochemically from
XFPs in Brainbow. By using Cre and Flp transgenic lines with distinct, defined specifities, it
should be possible to map separate sets of neurons in a single animal.
Finally, we generated Brainbow AAV vectors. These, along with recently described
Brainbow herpes viral vectors50 may be more useful than Brainbow transgenic mice in some
situations. Like Autobow, they avoid the need for double transgenic animals. Because time
of infection can be varied, they provide an alternative to use of CreER for temporal control.
Moreover, localized delivery of AAV enables tracing of connections from known sites to
multiple targets and discrimination of long-distance inputs from local connections.
The three most broadly useful Brainbow 3 lines (Brainbow 3.0 line D, Brainbow 3.1 line 3,
Brainbow 3.1 line 18 and Brainbow 3.2 line 7) have been provided to Jackson Laboratories
(www.jax.org) for distribution. Their stock numbers are xxx, xxx and xxx. The two AAVs
shown in Fig. 5 can be obtained from the University of Pennsylvania Vector Core
(www.med.upenn.edu/gtp/vectorcore/). Plasmids used to generate Brainbow 3.0, 3.1, and
3.2, Autobow, and Flpbow 1.1 and 3.1 mice, as well as bacterial expression vectors used to
produce immunogens, are available through Addgene, (www.addgene.org).
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METHODS
Brainbow Constructs
cDNA encoding the following fluorescent proteins were used: EGFP1, EYFP2, ECFP2,
mCerulean3, PhiYFP4 (Evrogen), mTFP5(Allele Biotechnology), TagBFP6 (Evrogen),
EBFP27 (Addgene), Kusabira-Orange8, TagRFPt9, mOrange29, tdTomato10, mCherry10,
mKate211 (Evrogen) and eqFP65012 (Evrogen). A HRAS farnesylation sequence51 was used
to tether XFPs to the cell membrane. A nuclear localization signal (NLS, APKKKRKV) was
added to the N-terminal end of PhiYFP(Y65A). WPRE sequence was used to stabilize
mRNA and enhance nuclear mRNA export30, 31. Polyadenylation signals were from the
SV40 t antigen for mouse transgenes and from the human Growth Hormone gene for AAV.
Brainbow constructs were assembled by standard cloning methods. A cloning scaffold
containing concatenate Lox mutant sequences and unique restriction digestion sites was
synthesized (DNA2.0, Inc., Menlo Park, CA) to facilitate cloning.
Brainbow modules were cloned into the pCMV- N1 mammalian expression vector
(Clontech) for transient mammalian cell expression. Brainbow mouse constructs were
cloned into a unique XhoI site in a genomic fragment of Thy1.2 containing neuron-specific
regulatory elements14. Brainbow AAV constructs were cloned into vectors provided by the
University of Pennsylvania Virus Core. Constructs were tested by expression in HEK293
cells (ATCC) prior to generation of mice or AAV.
Mice
Transgenic mice were generated by pronuclear injection at the Harvard Genome
Modification Core. Mice were maintained on C57B6 or CD-1 backgrounds. Brainbow mice
were crossed to mice that expressed Cre or Flp recombinases, including PV-Cre32, Islet-
Cre33, CreER34, L7-Cre35, ChAT-Cre36, Thy1-cre37, Wnt-flp43 and Actin-flp42. All
experiments conformed to NIH guidelines and were carried out in accordance with protocols
approved by the Harvard University Standing Committee on the Use of Animals in Research
and Teaching.
AAV
Two Brainbow AAVs were mixed to equal titer (7.5E12 genome copy/mL) before injection.
For retina injection, adult mice were anesthetized with ketamine-xylazine by intraperitoneal
injection. A small hole was made in the temporal eye by puncturing the sclera below the
cornea with a 30 1/2 G needle. Using a Hamilton syringe with a 33G blunt-ended needle,
0.5–1 µL of AAV virus was injected intravitreally. After injections, animals were treated
with Antisedan (Zoetic) and monitored for full recovery. For cortex injection, adult mice
were anesthetized with isoflurane via continuous delivery through a nose-cone and fixed to a
stereotaxic apparatus Surgery took place under sterile conditions with the animal lying on a
heating pad. 1 µL of 1:5 saline diluted AAV mix (1.5E12 genome copy/mL) was injected
over 10 minutes. The head wound was sutured at the end of the experiment. One injection of
the non-steroidal anti-inflammatory agent Meloxicam was given at the end of the surgery
and mice were kept on a heating pad with accessible moistened food pellets and/or
HydroGel until fully recovered. The mice were given another dose of Meloxicam one day
later and examined 4–6 weeks infection.
Antibodies
Expression vectors were constructed to produce His tag fusions of XFPs in E. coli. Proteins
were produced in bacterial, purified using His Fusion Protein Purification Kits (Thermo
Scientific), concentrated to > 3 mg/ml, and used as immunogens to produce rat anti-mTFP,
chicken anti-EGFP, rat anti-PhiYFP, rabbit anti-mCherry and guinea pig anti-mKate2.
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(Covance, Inc.). Chicken anti-EGFP IgY was purified from chicken egg yolks using Pierce
Chicken IgY Purification Kit (Thermo Scientific). Other sera were used without purification.
Other antibodies used were: rabbit anti-GFP (ab6556, Abcam), rabbit anti-PhiYFP
(#AB604, Evrogen), chicken anti-SUMOstar (#AB7002, LifeSensors Inc), Dylight 405
conjugated goat anti-rat (Jackson ImmunoResearch Laboratories, Inc.) and Alexa
fluorescent dye conjugated goat include anti-rat 488, anti-chicken 488 and 594, anti-rabbit
514 and 546, and anti-guinea pig 647 (Life Technologies Corporation).
Histology
Mice were anesthetized with sodium pentobarbital before intracardiac perfusion with 2–4%
paraformaldehyde in PBS. Brains were sectioned at 100 µm using a Leica vt1000s
vibratome. Muscle and retina were sectioned at 20 µm in a Leica CM1850 cryostat or
processed as whole mounts. For immunostaining, tissues were permeablized by 0.5% Triton
X-100 with 0.02% sodium azide in StartingBloc (Thermo Scientific) at room temperature
for 2 hours, then incubated with combinations of anti-XFPs (see above) for 24–48 hours at 4
°C. After extensive washing in PBST (0.01 M PBS with 0.1% Triton X-100), all secondary
antibodies (1:500) were added for 12 hours at 4 °C. Finally, sections and tissues were
mounted in Vectashield mounting medium (Vector Laboratory) and stored at −20 °C until
they were imaged.
Antibody combinations used in figures are as following: In Figure 1e–h, Figure 2b and d–g,
Figure 4d, Supplementary Figure 2a–d, Supplementary Figure 4b and Supplementary
Figure 5, primary antibodies are chicken anti-GFP (1:2,000), rabbit anti-mCherry (1:1,000,
for mOrange2) and guinea pig anti-mKate2 (1:500). Secondary antibodies are Alexa dye
conjugated goat anti-chicken488, anti-rabbit546, and anti-guinea pig647. In Figure 3b–d and
Supplementary Figure 2e, primary antibodies are chicken anti-GFP (for ECFP), rabbit anti-
PhiYFP (1:1,000) and guinea pig anti-mKate2. Secondary antibodies are Alexa dye
conjugated goat anti-chicken488, anti-rabbit546, and anti-guinea pig647. In Figure 4c, rabbit
anti-PhiYFP and Alexa dye conjugated goat anti-rabbit514 are used. In Figure 5d, primary
antibodies are rat anti-mTFP and rabbit anti-mCherry. Secondary antibodies are Alexa dye
conjugated goat anti-rat488 and anti-rabbit546. In Figure 5f–j and Supplementary Figure 9,
primary antibodies are guinea pig anti-mKate2 (for TagBFP), rat anti-mTFP (1:1,000),
chicken anti-GFP (for EYFP) and rabbit anti-mCherry. Secondary antibodies are Alexa dye
conjugated goat anti-rat488, anti-chicken488, anti-rabbit546, and anti-guinea pig647. In
Supplementary Figure 1, primary antibodies are rat anti-PhiYFP (1:1,000) and rabbit anti-
mCherry (1:1,000, for mOrange2). Secondary antibodies are Alexa dye conjugated goat
anti-rat488 and anti-rabbit546. In Supplementary Figure 7, primary antibodies are rabbit
anti-EGFP (1:1,000, for ECFP) and chicken anti-SUMOstar (1:1,000). Secondary antibodies
are Alexa dye conjugated goat anti-rabbit514 and anti-chicken594.
Imaging
Fixed brain and muscle samples were imaged using a Zeiss LSM710 confocal microscope.
Best separation of multiple fluorophores was obtained by using a 405 photodiode laser for
TagBFP and Dylight405, a 440 nm photodiode laser for mTFP, a 488 nm Argon line for
EGFP and Alexa488, a 514 nm Argon line for EYFP and Alexa514, a 561 nm photodiode
for mOrange2 and Alexa546, a 594 nm photodiode for mCherry, mKate2 and Alexa594 or a
633 nm photodiode for Alexa647. Images were obtained with 16× (0.8 NA), and 63× (1.45
NA) oil objectives. Confocal image stacks for all channels were acquired sequentially, and
maximally or 3D view projected using ImageJ (NIH). Intensity levels were uniformly
adjusted in ImageJ.
Cai et al. Page 8
Nat Methods. Author manuscript; available in PMC 2013 November 05.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Optimal imaging for Brainbow 3 tissue used a Zeiss LSM710 with fixed dichroic mirror
combinations of DM455+514/594 in order to reduce lag time between the two sequential
scans. EGFP and mKate2 are excited by 458 nm and 594 nm lasers simultaneously; and
fluorescence is collected at 465–580 nm in Channel 1 and 605–780 nm in Channel 2,
respectively. In a subsequent scan, 514 nm laser is used to excite mOrange2; and
fluorescence is collected at 545–600 nm in Channel 2. In the antibody amplified samples,
conjugated Alexa dyes normally produce much stronger fluorescence signal than XFPs. The
Zeiss microscope we used is optimized for imaging the Alexa488/546/647 combination. The
fixed dichroic mirror is DM488/561/633. Alexa488 and Alexa647 are excited by 488 nm
and 633 nm lasers simultaneously; and fluorescence is collected at 495–590 nm in Channel
1 and 638–780 nm in Channel 2, respectively. In the subsequent scan, 561 nm laser is used
to excite mOrange2; and fluorescence is collected at 566–626 nm in Channel 2.
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Figure 1. Brainbow 3 transgenic mice
(a–d) Steps in generation of Brainbow 3 transgenic mice. (a) Brainbow 1.0 (described in ref.
15). (b) Brainbow 3.0 incorporates farnesylated, antigenically distinct XFPs (mOrange2f,
EGFPf, and mKate2f) for membrane labeling and antibody amplification. (c) Brainbow 3.1
incorporates a nuclear-targeted non-fluorescent XFP (PhiNFPnls) in the first (default)
position to limit fluorescence to Cre-expressing cells while retaining the ability to screen
lines with a fourth antibody in the absence of Cre. (d) Brainbow 3.2 incorporates a WPRE
into Brainbow 3.1 to increase XFP levels. P, LoxP; 2, Lox2272; N, LoxN; W, WPRE; pA,
polyadenylation sequence.
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(e–g) Low (e) and high (f) power views of muscles from Brainbow 3.0 (line D); Islet-cre
mouse, showing terminal axons and neuromuscular junctions in extraocular muscle. (g)
Rotated image along dashed bar in (f) to show 5 motor axons labeled in distinct colors. The
open circles show that farnesylated XFPs mark plasma membranes more than cytoplasm.
(h) Cerebellum from Brainbow 3.1 (line 3); L7-Cre mouse. The 10 Purkinje cells in this
field are labeled by at least 7 distinct colors (antibody amplified and numbered i–vii).
Because Cre is selectively expressed by Purkinje cells in the L7-cre line, no other cell types
are labeled.
(i) Cerebellum from Brainbow 3.2 (line 7); CreER mouse showing granule native
fluorescence in red, pink, yellow, green, cyan, blue and brown. P, parallel fibers in
molecular layer. Purkinje cell bodies, which are unlabeled, are outlined.
Bars are 50µm in e, 20µm in f and h, 5µm in g, 10µm in i.
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Figure 2. Improved visualization of neurons in Brainbow 3 mice
(a,b) Cerebellum fromf Brainbow 1.0 (a) and Brainbow 3.1 (line3); L7Cre (b) mice. Left
and right panels in the middle show high magnification views of boxed regions in a and b,
respectively. The farnesylated XFPs clearly label the fine processes and dendritic spines
(arrows, middle right), which are missing in the cytoplasmic labeling (middle left).
(c,d) Retina from a Brainbow 3.0 (line D); Islet-cre mouse expressing EGFP (blue),
mOrange2 (green) and mKate2 (red). c shows Intrinsic XFP fluorescence and d shows a
nearby section immunostained with chicken-anti-GFP, rabbit-anti-mOrange2 and guinea
Cai et al. Page 14
Nat Methods. Author manuscript; available in PMC 2013 November 05.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
pig-anti-mKate2. Immunostaining enhances fluorescence and the number of labeled neurons
and processes without compromising color diversity.
(e–i) Immunostained cerebellum section from Brainbow 3.2 (line 7);PV-cre mouse. Separate
channels of region boxed in e are shown in f–h. The fraction of all labeled neurons that
express EGFP (f), mOrange2 (g) or mKate2 (h) is indicated in I (2037 neurons from 15
regions).
Bars are 40µm in a and b, 20µm in c and d, 25µm in e–g, 10µm in inserts.
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Figure 3. Autobow
(a) In Autobow, a self-excising Cre recombinase cDNA is placed in the first (default)
position. Once expressed, Cre can lead to expression of any of the 3 following XFPs
(outcomes 1–3), but is itself excised in the process, terminating recombination.
(b) Labeling of hippocampal neurons by Autobow founder 3. The 20 large neurons
(diameter <5µm) in this section are labeled in 20 distinct colors. Antibody amplified
Cerulean, PhiYFP and mKate2 are in blue, green and red, respectively.
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(c,d) Cortical neurons of an Autobow mouse line show similar color palette in the second (c)
and sixth (d) generations. Antibody amplified Cerulean, PhiYFP and mKate2 are in blue,
green and red, respectively. Bars are 50µm.
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Figure 4. Flpbow
(a,b) Flpbow transgenes incorporate Frt sites, which are substrates for Flp recombinase,
instead of Lox sites, which are substrates for Cre recombinase. In Flpbow 1 (a), the Lox
sites of Brainbow 1.0 were replaced by incompatible Frt sites Frt5T2 and Frt545. In Flpbow
3 (b), the Lox sites of Brainbow 3.2 were replaced by incompatible Frt sites F3, Frt5T2 and
Frt545. In addition, XFPs in this construct were fused to SUMO-Star, providing an epitope
tag.
(c) Labeling of neurons in caudate putamen of Flpbow 1; Wnt-flp double transgenic.
Neurons are labeled by at least nine colors (red, orange, yellow, yellow-green, green, cyan,
blue, purple, pink). Native fluorescence of ECFP, tdTomato and antibody amplified PhiYFP
are in blue, red and green, respectively.
(d) Labeling of mossy fibers in Flpbow3; Wnt-flp double transgenic. Fluorescence of
antibody amplified EGFP, mOrange2 and mKate2 are in blue, red and green, respectively.
Bars are 50µm in c, 20µm in d.
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Figure 5. Brainbow AAV
(a) AAV Brainbow constructs and recombination scheme. Farnesylated TagBFP and EYFP
or mCherry and mTFP were placed in reverse orientation between mutant Lox sites. EF1α,
regulatory elements from elongation factor 1α gene; W, WPRE; triangles, Lox mutants and
their recombination products; dark and light sectors indicate wild-type and mutant portions
of Lox sites, respectively; 1–6, recombination events.
(b) Outcomes of recombination events numbered in a. Open arrows, direction of intervening
cDNA; X, fully mutant (light green) lox site cannot serve as substrate for Cre.
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(c) Eight color outcomes resulting from pairs of Brainbow AAVs following recombination
as shown in a. This is a minimum value, because it does not account for differences in
relative intensity of the four XFPs
(d,e) Test of color balance. The mTFPf-mCherryf AAV vector was injected at low titer into
the cortex of a Thy1-Cre mouse and neurons of each color were counted. Similar fractions
of neurons expressed mTFPf (58%) and mCherryf (42%; n=1523 neurons in 4 sections of
three mice; red shows standard deviation.)
(f–h) AAV injected into cortex of PV-cre mice predominantly labels interneurons. g and h,
high magnification views of boxed regions in f.
(i) AAV injected into retina of mouse expressing Cre in retinal ganglion cell subset shows
labeling of ganglion cell somata, dendrites (arrow) and axons (arrowhead).
(j) AAV injected into cerebellum of PV-Cre mouse labels Purkinje cells (fan shaped
dendrites, white arrows) and interneurons (cell bodies and axons, yellow arrows).
In f–j antibody amplified mTFP and EYFP were in green; TagBFP was in blue and mCherry
was in red.
Bars are 20µm in f, 10µm in g and h, 50µm in i and j
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Figure 6. Processing a Brainbow image
(a) Original image. (b) Region boxed in a. (c) Deconvolution, resulting in decreased noise
without sacrificing spatial resolution. (d) Intensity normalization, expanding perceptible
color range. (e) Color shift correction (see also Supplemenatry Fig. 10). (f) Fully processed
image.
Yellow arrows indicate sequence of the image processing. White arrowheads indicate
corresponding objects in the original and color-shift corrected images. Bars are 10µm in a
and f, 3µm in b–e.
Cai et al. Page 21
Nat Methods. Author manuscript; available in PMC 2013 November 05.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
